MYALEPTA DIN 02544555
Status: Marketed
Holder: CHIESI FARMACEUTICI S.P.A.
Health Canada record
| Active ingredient(s) | METRELEPTIN 3 MG |
|---|
| Dosage form | Powder For Solution |
|---|
| Route | Subcutaneous |
|---|
| Schedule | PRESCRIPTION; SCHEDULE D |
|---|
| Class | Human |
|---|
| ATC | A16AA07 METRELEPTIN |
|---|
| Original market date | 25-Oct-2024 |
|---|
| Current status date | 25-Oct-2024 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Chiesi Farmaceutici S.p.A. — licence , not currently licensed, last inspection rating C (2023-09-29).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METRELEPTIN
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02544563 | MYALEPTA | CHIESI FARMACEUTICI S.P.A. | Powder For Solution | METRELEPTIN 5.8 MG | Marketed |
| 02544571 | MYALEPTA | CHIESI FARMACEUTICI S.P.A. | Powder For Solution | METRELEPTIN 11.3 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 33766 | 2024-08-02 | New Drug Submission (NDS) | Administrative - Change in Product Ownership |
| 32544 | 2024-01-17 | New Drug Submission (NDS) | |
Request a quote for MYALEPTA
How to read a Canadian DIN record